Unhide® Project Also Known as The Unhide® Solve Together Unified Platform

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from individuals with brain inflammation and related neuroinflammatory conditions. Participants in the United States aged 2 years and older will provide self-reported health data, biometrics, and symptom diaries through the MyDataHelps™ app (branded as unhide® for this study). The goal is to create comprehensive longitudinal profiles to facilitate research into disease subtypes, causes, diagnostics, and potential treatments, as well as to identify potential participants for future optional studies. Healthy individuals without brain inflammation are also eligible to participate. The digital health research platform used in this study was originally developed and designed by Solve M.E and was called SolveTogether. The Brain Inflammation Collaborative (BIC) expanded upon Solve M.E.'s work to include related diagnoses, pediatric participants, enhance symptom tracking, and more. BIC and Solve M.E. combined Solve Together and unhide®, to create The unhide® Solve Together Unified Platform in 2025.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Healthy Volunteers: t
View:

⁃ Participants may be either self-diagnosed, or diagnosed by a physician with the following conditions:

• Infection-associated chronic conditions such as Long COVID, chronic Lyme, myalgic encephalomyelitis (ME/CFS), and post-acute neuropsychiatric syndrome (PANS/PANDAS).

• Neuroimmune, developmental, autonomic, and neurological conditions like migraines, dysautonomia, POTS, multiple sclerosis, and autism spectrum disorder.

• Autoimmune diseases such as Lupus, Sjogren's Disease, rheumatoid arthritis, myasthenia gravis, ankylosing spondylitis, and related autoimmune conditions.

⁃ Inflammatory gastrointestinal conditions such as Crohn's Disease, Celiac Disease, and ulcerative colitis.

• Behavioral and mood disorders such as anxiety, depression, bipolar disorder, PTSD, eating disorders, OCD, and other related conditions.

• Healthy people (without brain inflammation), including unaffected individuals, unaffected individuals in the same household, and unaffected individuals who are married to relatives and family members.

• Have consistent internet access and a cell phone, tablet, or PC since this is an online or app-based platform that requires entering data and completing surveys.

• Currently live in the United States

• Be able to participate in English (stay tuned for updates about the Spanish language version)

• Be willing to share symptom and health data through the platform

Locations
United States
Wisconsin
Brain Inflammation Collaborative
RECRUITING
Delafield
Contact Information
Primary
Megan L Fitzgerald, PhD
help@braininflammationcollaborative.org
1-833-286-4433
Backup
Christina Moon
help@braininflammationcollaborative.org
1-833-286-4433
Time Frame
Start Date: 2023-07-05
Estimated Completion Date: 2030-12-31
Participants
Target number of participants: 10000
Treatments
People with brain inflammation and related neuroinflammatory conditions
No intervention will be administered.
Healthy Controls
No intervention will be administered.
Sponsors
Collaborators: Columbia University, Solve ME/CFS Initiative, Care Evolution
Leads: Brain Inflammation Collaborative

This content was sourced from clinicaltrials.gov